Senate Hearing on High Drug Prices Focuses on Increased Generic Competition, Less on R&D Costs

The Senate Health, Education, Labor and Pensions Committee sought to answer basic questions on what is driving drug prices sky high, in a Tuesday hearing ostensibly dedicated to the pharmaceutical industry — though it was frequently derailed by Democrats’ concerns over Republican efforts to repeal and replace the Affordable Care Act.
Source: Drug Industry Daily